HKAM
KRSA

Horizon Kinetics Asset Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Horizon Kinetics Asset Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-524
Closed -$194K – 412
2020
Q1 		$194K Sell
524
-400
-43% -$28.5K 0.01% 321
2019
Q4 		$352K Buy
+924
New +$86.3K 0.01% 289

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horizon Kinetics Asset Management's KRSA Position: Q2 2020 in Review

Horizon Kinetics Asset Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2020, closing a stake of 524 shares — an estimated $194K sold.

Horizon Kinetics Asset Management first reported a position in KRSA in Q4 2019 and held it in 2 quarters. The position peaked at $352K in Q4 2019. 70 funds tracked by Wall St. Rank hold KRSA as of Q2 2020.

  • Horizon Kinetics Asset Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Horizon Kinetics Asset Management sold 524 Korsana Biosciences, Inc. Common Stock shares in Q2 2020, an estimated $194K.
  • Horizon Kinetics Asset Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Horizon Kinetics Asset Management's Korsana Biosciences, Inc. Common Stock position peaked at $352K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2020.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.